United Therapeutics Corporation (UTHR) News

United Therapeutics Corporation (UTHR): $358.93

7.46 (-2.04%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

B

Add UTHR to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#8 of 337

in industry

Filter UTHR News Items

UTHR News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

UTHR News Highlights

  • 404 Page not found

    Error: Page not found

    The requested URL was not found on this server.

  • 404 Page not found

    Error: Page not found

    The requested URL was not found on this server.

  • 404 Page not found

    Error: Page not found

    The requested URL was not found on this server.

Latest UTHR News From Around the Web

Below are the latest news stories about UNITED THERAPEUTICS CORP that investors may wish to consider to help them evaluate UTHR as an investment opportunity.

Here's Why United Therapeutics (UTHR) is a Strong Growth Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Yahoo | January 10, 2025

Here's Why United Therapeutics (UTHR) is a Strong Value Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Yahoo | January 9, 2025

Are Medical Stocks Lagging United Therapeutics (UTHR) This Year?

Here is how United Therapeutics (UTHR) and AnaptysBio, Inc. (ANAB) have performed compared to their sector so far this year.

Yahoo | January 9, 2025

UTHR vs. STVN: Which Stock Is the Better Value Option?

UTHR vs. STVN: Which Stock Is the Better Value Option?

Yahoo | January 8, 2025

How to Find Strong Medical Stocks Slated for Positive Earnings Surprises

Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.

Yahoo | January 8, 2025

United Therapeutics Corporation to Present at the 43rd Annual J.P. Morgan Healthcare Conference

SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C., January 06, 2025--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced today that Dr. Martine Rothblatt, Chairperson and Chief Executive Officer, will provide an overview and update on the company’s business during a presentation at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco.

Yahoo | January 6, 2025

We Ran A Stock Scan For Earnings Growth And United Therapeutics (NASDAQ:UTHR) Passed With Ease

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...

Yahoo | December 29, 2024

United Therapeutics Corporation (UTHR): Among the Cheap Healthcare Stocks to Buy Heading Into 2025

We recently compiled a list of the 12 Cheap Healthcare Stocks to Buy Heading into 2025. In this article, we are going to take a look at where United Therapeutics Corporation (NASDAQ:UTHR) stands against the other cheap healthcare stocks. The Resilience and Challenges of Global Healthcare Spending Investing in healthcare equities is typically seen as protective […]

Yahoo | December 28, 2024

Why United Therapeutics (UTHR) is a Top Growth Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Yahoo | December 25, 2024

Is United Therapeutics (UTHR) the Best Performing Biotech Stock in 2024?

We recently compiled a list of the 10 Best Performing Biotech Stocks in 2024. In this article, we are going to take a look at where United Therapeutics Corporation (NASDAQ:UTHR) stands against the other biotech stocks. The Booming Biotechnology Sector The biotechnology sector is expanding quickly due to rising demand for novel therapies, advancement in technology, […]

Yahoo | December 24, 2024


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!